Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

ProPhase Labs Inc (NASDAQ:PRPH)

2.28
Delayed Data
As of 1:00pm ET
 +0.01 / +0.44%
Today’s Change
1.78
Today|||52-Week Range
2.45
+14.00%
Year-to-Date
SECTOR
Consumer Non-Durables
INDUSTRY
Household/Personal Care
MARKET CAP
$28.2M

Company Description

ProPhase Labs, Inc. engages in the manufacturing, distribution and marketing of homeopathic and health care products. Its products include Cold-EEZE, Tk supplement, natural allergy relief, cold and flu relief and Organix Rx Complete. The company engages in the research and development of drugs and natural base health products, which includes supplements, personal care and cosmeceutical products. ProPhase Labs was founded by Guy J. Quigley and Charles A. Phillips in July 1989 and is headquartered in Doylestown, PA.

Contact Information

ProPhase Labs, Inc.
621 North Shady Retreat Road
Doylestown Pennsylvania 18901
P:(215) 345-0919
Investor Relations:
121534509190

Employees

Shareholders

Individual stakeholders77.34%
Other institutional12.75%
Mutual fund holders1.15%

Top Executives

Ted William KarkusChairman & Chief Executive Officer
Monica BradyChief Financial & Accounting Officer